Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of GBP 133.33 billion. The enterprise value is 167.21 billion.

Market Cap	133.33B
Enterprise Value	167.21B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 21, 2025

Share Statistics

Current Share Class	538.48M
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	80.83%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 25.58 and the forward PE ratio is 15.92.

PE Ratio	25.58
Forward PE	15.92
PS Ratio	4.98
PB Ratio	18.63
P/TBV Ratio	n/a
P/FCF Ratio	15.53
P/OCF Ratio	13.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.35, with an EV/FCF ratio of 19.48.

EV / Earnings	32.09
EV / Sales	6.19
EV / EBITDA	13.35
EV / EBIT	19.96
EV / FCF	19.48

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 5.67.

Current Ratio	1.28
Quick Ratio	0.82
Debt / Equity	5.67
Debt / EBITDA	3.27
Debt / FCF	4.73
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is 81.71% and return on invested capital (ROIC) is 10.56%.

Return on Equity (ROE)	81.71%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	10.56%
Return on Capital Employed (ROCE)	16.33%
Revenue Per Employee	955,724
Profits Per Employee	186,118
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.57

Taxes

In the past 12 months, Amgen has paid 921.74 million in taxes.

Income Tax	921.74M
Effective Tax Rate	15.03%

Stock Price Statistics

The stock price has increased by +23.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+23.27%
50-Day Moving Average	310.87
200-Day Moving Average	296.67
Relative Strength Index (RSI)	61.46
Average Volume (20 Days)	11,883

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.09

Income Statement

In the last 12 months, Amgen had revenue of GBP 26.76 billion and earned 5.21 billion in profits. Earnings per share was 9.62.

Revenue	26.76B
Gross Profit	18.75B
Operating Income	8.30B
Pretax Income	6.13B
Net Income	5.21B
EBITDA	12.26B
EBIT	8.30B
Earnings Per Share (EPS)	9.62

Full Income Statement

Balance Sheet

The company has 7.03 billion in cash and 40.61 billion in debt, giving a net cash position of -33.58 billion.

Cash & Cash Equivalents	7.03B
Total Debt	40.61B
Net Cash	-33.58B
Net Cash Per Share	n/a
Equity (Book Value)	7.16B
Book Value Per Share	13.29
Working Capital	4.53B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.76 billion and capital expenditures -1.18 billion, giving a free cash flow of 8.58 billion.

Operating Cash Flow	9.76B
Capital Expenditures	-1.18B
Free Cash Flow	8.58B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.05%, with operating and profit margins of 31.02% and 19.47%.

Gross Margin	70.05%
Operating Margin	31.02%
Pretax Margin	22.92%
Profit Margin	19.47%
EBITDA Margin	45.82%
EBIT Margin	31.02%
FCF Margin	32.08%

Dividends & Yields

This stock pays an annual dividend of 7.26, which amounts to a dividend yield of 2.11%.

Dividend Per Share	7.26
Dividend Yield	2.11%
Dividend Growth (YoY)	2.40%
Years of Dividend Growth	6
Payout Ratio	72.03%
Buyback Yield	-0.28%
Shareholder Yield	1.83%
Earnings Yield	3.91%
FCF Yield	6.44%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.69 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	7